Reuß AM, Groos D, Ghoochani A, Buchfelder M, Savaskan N (2021)
Publication Type: Journal article
Publication year: 2021
Book Volume: 2021
Article Number: 6655529
DOI: 10.1155/2021/6655529
Monocarboxylate transporter 4 (MCT4, SLC16A3) is elevated under hypoxic conditions in many malignant tumors including gliomas. Moreover, MCT4 expression is associated with shorter overall survival. However, the functional consequences of MCT4 expression on the distinct hallmarks of cancer have not yet been explored at the cellular level. Here, we investigated the impact of MCT4 overexpression on proliferation, survival, cell death, migration, invasion, and angiogenesis in F98 glioma cells. Stable F98 glioma cell lines with MCT4 overexpression, normal expression, and knockdown were generated. Distinct hallmarks of cancer were examined using in silico analysis, various in vitro cell culture assays, and ex vivo organotypic rat brain slice culture model. Consistent with its function as lactate and proton exporter, MCT4 expression levels correlated inversely with extracellular pH and proportionally with extracellular lactate concentrations. Our results further indicate that MCT4 promotes proliferation and survival by altered cell cycle regulation and cell death mechanisms. Moreover, MCT4 overexpression enhances cell migration and invasiveness via reorganization of the actin cytoskeleton. Finally, MCT4 inhibition mitigates the induction of angiogenesis, suggesting that MCT4 also plays a crucial role in tumor-related angiogenesis. In summary, our data highlight MCT4/SLC16A3 as a key gene for distinct hallmarks of tumor malignancy in glioma cells.
APA:
Reuß, A.M., Groos, D., Ghoochani, A., Buchfelder, M., & Savaskan, N. (2021). MCT4 Promotes Tumor Malignancy in F98 Glioma Cells. Journal of Oncology, 2021. https://dx.doi.org/10.1155/2021/6655529
MLA:
Reuß, Anna Maria, et al. "MCT4 Promotes Tumor Malignancy in F98 Glioma Cells." Journal of Oncology 2021 (2021).
BibTeX: Download